Precision Capital
Advancing Precision Health
Contact Us
Improving Healthcare Through Disruptive Innovation
Medical Excellence Capital (MEC) is an early stage life sciences fund that combines a unique global network of leading physician scientists with a team of experienced investors, company builders, and operators.
Focusing on the Future of Precision Health
At MEC, we believe the post Covid-19 era will lead to a golden age in innovation within the life sciences space.
MEC invests in company creation, seed and Series A opportunities where technology and novel approaches are transformational including, but not limited to:
- Gene Therapy
- Cell Therapy
- Synthetic Biology
- Regenerative Medicine
- AI-Enabled Drug Discovery & Development
Tapping into a Global Network of Opportunity
MEC leverages Medical Excellence Group’s (MedEx) proprietary physician and academic medical center platform to curate a unique deal flow of emerging, breakthrough technologies thoroughly vetted by our own team of industry experts.
and Scientists
Medical Centers
Offices
Leveraging Unparalleled Industry Expertise
We created the MEC Council, a carefully-curated subset of our 1,100+ physician/scientist panel to create a unique competitive edge. The Council enables us to get smart very quickly on a complex business opportunity theme, evaluate an investment hypothesis, or to accelerate the development of an existing MEC portfolio company.
MEC Council members include acclaimed subject matter experts across all areas of healthcare and biotech, from drug discovery researchers to experts in clinical development and regulatory requirements.
Purpose Built Team
MEC is comprised of seasoned investors and health venture operators, each with a track record of success across multiple sectors in healthcare investment and operating environments.

John Prufeta, MBA
Founder, CEO & General Partner
Eric Heil, MBA
Managing Partner
Kim Kamdar, PhD
Managing Partner
Brian Halak, PhD
Managing Partner
Joni Mancini, CPA
Managing Partner & COO/CFO
Olga Prufeta
MEC LP Liaison;Medical Excellence Group

John Hornbostel, Esq.
Counsel
Kevin Emesiani, PharmD, MBA
AssociateEngaging with World-Class Scientific Advisors
Acclaimed innovators themselves in the fields of regenerative medicine, gene therapy, and mitochondrial medicine, the MEC scientific advisory board brings critical perspective to evaluating new opportunities and providing added value to portfolio companies.

Euan Ashley
MB ChB, PhD
Stanford

Juan-Carlos
Belmonte, PhD
Salk Institute

Gregg Semenza
MD, PhD
2019 Nobel LaureateJohns Hopkins

Stephen Tsang
MD, PhD
Columbia

Douglas Wallace
PhD
CHOP | UPenn
Learn More About MEC
For more information on Medical Excellence Capital and our investment strategy, please refer to the resources below or contact us.
Take the Next Step
Contact us today for more information about MEC.